phase 11 - (Mayo) Ovarian Cancer Clinical Trial: Intra-op Detection of Occult Ovarian Carcinoma Using a Folate-Alpha Receptor Specific Fluorescent Ligand

Blogger's Note: as per criteria, recurrent ovarian cancer patients do not qualify for this study

Verified by: Mayo Clinic, January 2012

First Received: January 12, 2012 | Last Updated: January 17, 2012 | Phase: Phase 2 | Start Date: January 2012

Overall Status: Not yet recruiting | Estimated Enrollment: 50